Mice with a mutated growth hormone receptor are long-lived (List et al., 2011), and in humans, longer lives and cancer protection are observed in Laron Syndrome patients (dwarfism due to a growth hormone receptor mutation; Laron et al., 2017). This evidence concerns the gene GHR and cancer.